USANA Health Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measures (Tables)

Fair Value Measures (Tables)

3 Months Ended

Mar. 28, 2020

Schedule Of Assets And Liabilities Measured At Fair Value



			Fair Value Measurements Using
	March 28,		Inputs
	2020		Level 1		Level 2		Level 3
Money market funds included in cash equivalents	$	139,404	$	139,404	$	—	$	—
Net investment hedge included in prepaid expenses and other current assets		1,939		—		1,939		—
Foreign currency contracts included in prepaid expenses and other current assets		323		—		323		—
	$	141,666	$	139,404	$	2,262	$	—

			Fair Value Measurements Using
	December 28,		Inputs
	2019		Level 1		Level 2		Level 3
Money market funds included in cash equivalents	$	180,032	$	180,032	$	—	$	—
Foreign currency contracts included in other current liabilities		(764)		—		(764)		—
	$	179,268	$	180,032	$	(764)	$	—

- Definition

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

+ References + Details